• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性疟原虫对抗叶酸药物的阶段特异性敏感性。

Stage-specific sensitivity of Plasmodium falciparum to antifolates.

作者信息

Dieckmann A, Jung A

出版信息

Z Parasitenkd. 1986;72(5):591-4. doi: 10.1007/BF00925479.

DOI:10.1007/BF00925479
PMID:3535282
Abstract

Highly synchronous cultures of Plasmodium falciparum were exposed to therapeutic concentrations of sulfadoxine or pyrimethamine at different developmental stages to investigate the effect on subsequent growth. Morphological observations showed that schizont formation from uninuclear trophozoites was the only process inhibited by the drugs. Segmentation of mature schizonts, merozoite invasion and development of the ring stage remained unaffected. These results support earlier reports suggesting that DNA synthesis is most pronounced in 32-42 h old trophozoites. The possible relevance of our results to the metabolism of P. falciparum is discussed.

摘要

将恶性疟原虫的高度同步培养物在不同发育阶段暴露于治疗浓度的磺胺多辛或乙胺嘧啶中,以研究对后续生长的影响。形态学观察表明,从单核滋养体形成裂殖体是唯一受药物抑制的过程。成熟裂殖体的分裂、裂殖子入侵和环状体发育均未受影响。这些结果支持了早期的报告,即DNA合成在32-42小时龄的滋养体中最为明显。讨论了我们的结果与恶性疟原虫代谢的可能相关性。

相似文献

1
Stage-specific sensitivity of Plasmodium falciparum to antifolates.恶性疟原虫对抗叶酸药物的阶段特异性敏感性。
Z Parasitenkd. 1986;72(5):591-4. doi: 10.1007/BF00925479.
2
Synergistic antimalarial activity of pyrimethamine and sulfadoxine against Plasmodium falciparum in vitro.乙胺嘧啶和磺胺多辛对恶性疟原虫的体外协同抗疟活性。
Am J Trop Med Hyg. 1984 May;33(3):325-30. doi: 10.4269/ajtmh.1984.33.325.
3
Optimal concentration of p-aminobenzoic acid and folic acid in the in vitro assay of antifolates against Plasmodium falciparum.对恶性疟原虫进行抗叶酸体外测定时对氨基苯甲酸和叶酸的最佳浓度
Am J Trop Med Hyg. 1987 Jul;37(1):42-8. doi: 10.4269/ajtmh.1987.37.42.
4
Evaluation of an in vitro test method for the assessment of sensitivity of Plasmodium falciparum to pyrimethamine and sulfadoxine.评估恶性疟原虫对乙胺嘧啶和磺胺多辛敏感性的体外试验方法
Bull World Health Organ. 1987;65(3):345-52.
5
In vitro sensitivity of Plasmodium falciparum to sulfadoxine and pyrimethamine.恶性疟原虫对周效磺胺和乙胺嘧啶的体外敏感性
Southeast Asian J Trop Med Public Health. 1985 Jun;16(2):296-301.
6
Efficacy of Fansidar against Plasmodium falciparum in continuous culture.Fansidar对恶性疟原虫连续培养的疗效。
Am J Trop Med Hyg. 1982 Sep;31(5):913-8. doi: 10.4269/ajtmh.1982.31.913.
7
Cross resistance of pyrimethamine and sulfadoxine to their related compounds in Plasmodium falciparum.
Southeast Asian J Trop Med Public Health. 1984 Mar;15(1):7-11.
8
Continuous cultivation and improved drug responsiveness of Plasmodium falciparum in p-aminobenzoic acid-deficient medium.恶性疟原虫在对氨基苯甲酸缺乏的培养基中的连续培养及药物反应性改善
J Parasitol. 1983 Apr;69(2):353-9.
9
Analysis of resistance to pyrimethamine/sulphadoxine of isolates of Plasmodium falciparum from Eastern Thailand.
Trans R Soc Trop Med Hyg. 1986;80(1):66-8. doi: 10.1016/0035-9203(86)90198-7.
10
Mefloquine and sulfadoxine/pyrimethamine resistant Plasmodium falciparum.对甲氟喹和磺胺多辛/乙胺嘧啶耐药的恶性疟原虫。
Lancet. 1986 Jan 18;1(8473):154. doi: 10.1016/s0140-6736(86)92287-7.

引用本文的文献

1
Integral Solvent-Induced Protein Precipitation for Target-Engagement Studies in .用于……中靶点结合研究的整体溶剂诱导蛋白质沉淀法
ACS Infect Dis. 2024 Dec 13;10(12):4073-4086. doi: 10.1021/acsinfecdis.4c00418. Epub 2024 Dec 4.
2
New Insights into Antimalarial Chemopreventive Activity of Antifolates.抗叶酸药的抗疟化学预防作用的新见解。
Antimicrob Agents Chemother. 2022 Feb 15;66(2):e0153821. doi: 10.1128/AAC.01538-21. Epub 2021 Dec 20.
3
Incorporating Stage-Specific Drug Action into Pharmacological Modeling of Antimalarial Drug Treatment.

本文引用的文献

1
Phospholipid biosynthesis in synchronous Plasmodium falciparum cultures.恶性疟原虫同步培养物中的磷脂生物合成
J Protozool. 1982 May;29(2):258-63. doi: 10.1111/j.1550-7408.1982.tb04023.x.
2
Polyamine levels and the activity of their biosynthetic enzymes in human erythrocytes infected with the malarial parasite, Plasmodium falciparum.感染疟原虫恶性疟原虫的人类红细胞中的多胺水平及其生物合成酶的活性。
Biochem J. 1984 Sep 15;222(3):815-9. doi: 10.1042/bj2220815.
3
Synthesis of DNA during the asexual cycle of Plasmodium falciparum in culture.
将阶段特异性药物作用纳入抗疟药物治疗的药理模型
Antimicrob Agents Chemother. 2016 Apr 22;60(5):2747-56. doi: 10.1128/AAC.01172-15. Print 2016 May.
4
The role of antioxidants treatment on the pathogenesis of malarial infections: a review.抗氧化剂治疗在疟疾感染发病机制中的作用:综述。
Parasitol Res. 2014 Mar;113(3):801-9. doi: 10.1007/s00436-014-3804-1. Epub 2014 Feb 13.
5
Fast in vitro methods to determine the speed of action and the stage-specificity of anti-malarials in Plasmodium falciparum.快速体外方法测定抗疟药在恶性疟原虫中的作用速度和阶段特异性。
Malar J. 2013 Nov 16;12:424. doi: 10.1186/1475-2875-12-424.
6
Antimalarial drug resistance: a review of the biology and strategies to delay emergence and spread.抗疟药耐药性:生物学与延迟出现和传播策略的综述。
Int J Antimicrob Agents. 2013 Apr;41(4):311-7. doi: 10.1016/j.ijantimicag.2012.12.007. Epub 2013 Feb 8.
7
Oleic acid biosynthesis in Plasmodium falciparum: characterization of the stearoyl-CoA desaturase and investigation as a potential therapeutic target.恶性疟原虫中油酸的生物合成:硬脂酰辅酶A去饱和酶的特性及作为潜在治疗靶点的研究
PLoS One. 2009 Sep 3;4(9):e6889. doi: 10.1371/journal.pone.0006889.
8
Patterns of gene-specific and total transcriptional activity during the Plasmodium falciparum intraerythrocytic developmental cycle.恶性疟原虫红细胞内发育周期中基因特异性和总转录活性模式。
Eukaryot Cell. 2009 Mar;8(3):327-38. doi: 10.1128/EC.00340-08. Epub 2009 Jan 16.
9
Potent inhibitors of Plasmodium phospholipid metabolism with a broad spectrum of in vitro antimalarial activities.具有广泛体外抗疟活性的疟原虫磷脂代谢强效抑制剂。
Antimicrob Agents Chemother. 2003 Aug;47(8):2590-7. doi: 10.1128/AAC.47.8.2590-2597.2003.
10
Assessment of the pharmacodynamic properties of antimalarial drugs in vivo.体内抗疟药物药效学特性评估。
Antimicrob Agents Chemother. 1997 Jul;41(7):1413-22. doi: 10.1128/AAC.41.7.1413.
恶性疟原虫在培养中的无性生殖周期内DNA的合成。
Mol Biochem Parasitol. 1984 Jan;10(1):79-87. doi: 10.1016/0166-6851(84)90020-3.
4
Plasmodium falciparum: synchronization of asexual development with aphidicolin, a DNA synthesis inhibitor.恶性疟原虫:使用DNA合成抑制剂阿非迪霉素同步无性发育。
Exp Parasitol. 1984 Feb;57(1):48-54. doi: 10.1016/0014-4894(84)90061-4.
5
Protein and nucleic acid synthesis during synchronized growth of Plasmodium falciparum.恶性疟原虫同步生长期间的蛋白质和核酸合成
J Bacteriol. 1984 Dec;160(3):1165-7. doi: 10.1128/jb.160.3.1165-1167.1984.
6
The mechanism of pyrimethamine resistance in Plasmodium falciparum.
Parasitology. 1986 Oct;93 ( Pt 2):275-8. doi: 10.1017/s0031182000051441.
7
Mechanisms of sulfadoxine resistance in Plasmodium falciparum.恶性疟原虫对周效磺胺耐药的机制。
Mol Biochem Parasitol. 1986 May;19(2):143-7. doi: 10.1016/0166-6851(86)90119-2.
8
Human malaria parasites in continuous culture.持续培养中的人类疟原虫。
Science. 1976 Aug 20;193(4254):673-5. doi: 10.1126/science.781840.
9
Synchronization of Plasmodium falciparum erythrocytic stages in culture.恶性疟原虫红细胞内期在培养中的同步化
J Parasitol. 1979 Jun;65(3):418-20.